Evidence map›Paper›PMID 25795419›Full record

ArticleJournal of immunological methods2015

Utilization of imaging flow cytometry to define intermediates of megakaryopoiesis in vivo and in vitro.

Kathleen E McGrath

Abstract read
In one paragraph

Article in Journal of immunological methods, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Laboratory Assessment and Clinical Outlook forAnnals of laboratory medicine · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Kathleen E McGrathDepartment of Pediatrics, Center for Pediatric Biomedical Research, University of Rochester Medical Center, Rochester, NY 14642, United States. Electronic address: kathleene_mcgrath@urmc.rochester.edu.
University of Rochester Medical Center · US

Funding

PGE2 mitigation of acute and late radiation injuryU01AI107276 · NIAID · UNIVERSITY OF ROCHESTER · PI CALVI, LAURA M, PALIS, JAMES · 2013 to 2017
$2.9M
Megakaryocyte and platelet ontogenyR01DK098251 · NIDDK · UNIVERSITY OF ROCHESTER · PI PALIS, JAMES · 2013 to 2017
$1.8M
NIAID NIH HHS U01 AI107276NIDDK NIH HHS R01 DK098251
6 · The paper itself

Abstract

Imaging flow cytometry is a particularly powerful analytical approach for the study of megakaryopoiesis. It can utilize well-defined immunophenotypic markers as well as assess maturation of megakaryocytes by their increasing ploidy as they endoreplicate. Imaging flow cytometry can also assess morphometric cell characteristics of size and nuclear to cytoplasmic ratio, which are informative indications of maturation. However, megakaryopoiesis is challenging for flow cytometric analysis, particularly in vivo, because megakaryocytes are very rare in the bone marrow and their odd shape, high DNA content and cell size are similar to clumps of cells. Additionally, both megakaryocytes and immunophenotypically similar platelets are frequently found associated with other cells. Due to these challenges, imaging flow cytometry of megakaryopoiesis exemplifies several strengths of this approach in utilizing fluorescent signal's shape, texture and overlap with other fluorescent signals to distinguish megakaryocytes from a variety of contaminants and to restrict analysis to megakaryocytes, even when associated with other cells. Presented here is a strategy for imaging flow cytometric analysis of rare murine megakaryocytes directly from the bone marrow as well those grown in vitro and analyzed as live cells, or after fixation and permeabilization.

Indexed as

AnimalsBlood PlateletsBone MarrowBone Marrow CellsCell SizeFlow CytometryImage CytometryIn Vitro TechniquesMegakaryocytesMicePloidiesBone marrowImaging flow cytometryMegakaryocytePlatelet

Identifiers

PMID25795419
PMCPMC4522210
OpenAlexW2044046903

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.